Enzon Pharmaceuticals Inc
Enzon Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the sale of its patented drug product, PegIntron. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.
Enzon Pharmaceuticals Inc (ENZN) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 1.125x
Based on the latest financial reports, Enzon Pharmaceuticals Inc (ENZN) has a cash flow conversion efficiency ratio of 1.125x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.04 Million) by net assets ($-923.00K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Enzon Pharmaceuticals Inc - Cash Flow Conversion Efficiency Trend (2000–2024)
This chart illustrates how Enzon Pharmaceuticals Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Enzon Pharmaceuticals Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Enzon Pharmaceuticals Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tempest Minerals Ltd
AU:TEM
|
0.034x |
|
FirstCaution SA
PA:MLFIR
|
N/A |
|
Qualigen Therapeutics Inc
NASDAQ:QLGN
|
-0.056x |
|
Mehadrin
TA:MEDN
|
-0.080x |
|
COFLE S.P.A.
F:Y9A
|
N/A |
|
Polyram Plastic Industries Ltd
TA:POLP
|
0.072x |
|
One World Lithium Inc
OTCQB:OWRDF
|
0.056x |
|
AGATOS S.P.A.
F:5JS1
|
N/A |
Annual Cash Flow Conversion Efficiency for Enzon Pharmaceuticals Inc (2000–2024)
The table below shows the annual cash flow conversion efficiency of Enzon Pharmaceuticals Inc from 2000 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $3.01 Million | $1.12 Million | 0.373x | +0.18% |
| 2023-12-31 | $3.50 Million | $1.30 Million | 0.372x | +2692.72% |
| 2022-12-31 | $45.89 Million | $-659.00K | -0.014x | +86.05% |
| 2021-12-31 | $4.87 Million | $-501.00K | -0.103x | -1195.13% |
| 2020-12-31 | $47.82 Million | $-380.00K | -0.008x | -100.70% |
| 2019-12-31 | $6.05 Million | $6.91 Million | 1.140x | +1848.23% |
| 2018-12-31 | $14.99 Million | $-978.00K | -0.065x | -109.22% |
| 2017-12-31 | $9.14 Million | $6.47 Million | 0.708x | +181.30% |
| 2016-12-31 | $10.33 Million | $2.60 Million | 0.252x | -69.00% |
| 2015-12-31 | $18.09 Million | $14.68 Million | 0.811x | -25.72% |
| 2014-12-31 | $29.60 Million | $32.34 Million | 1.092x | -59.01% |
| 2013-12-31 | $5.25 Million | $14.01 Million | 2.665x | +2342.72% |
| 2012-12-31 | $77.47 Million | $8.45 Million | 0.109x | +269.06% |
| 2011-12-31 | $197.18 Million | $-12.72 Million | -0.065x | -194.70% |
| 2010-12-31 | $331.86 Million | $22.61 Million | 0.068x | -73.86% |
| 2009-12-31 | $53.28 Million | $13.89 Million | 0.261x | -64.40% |
| 2008-12-31 | $41.66 Million | $30.51 Million | 0.732x | -73.33% |
| 2007-12-31 | $36.57 Million | $100.43 Million | 2.746x | +457.89% |
| 2006-12-31 | $-56.44 Million | $43.31 Million | -0.767x | -801.43% |
| 2004-12-31 | $203.50 Million | $22.26 Million | 0.109x | -14.74% |
| 2003-12-31 | $289.09 Million | $37.09 Million | 0.128x | -38.18% |
| 2002-12-31 | $291.58 Million | $60.52 Million | 0.208x | +28.59% |
| 2001-12-31 | $190.50 Million | $30.75 Million | 0.161x | +303.92% |
| 2000-12-31 | $138.99 Million | $5.55 Million | 0.040x | -- |